SCHEMBL28092566

SCHEMBL28092566

O=C(Oc1cccc2cccnc12)N1CCNc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ POLB P06746 2/20 0.49
▸ LMNA P02545 4/20 0.49
▸ METAP2 P50579 2/20 0.49
▸ METAP1 P53582 2/20 0.49
▸ HDAC6 Q9UBN7 1/20 0.49
▸ L3MBTL1 Q9Y468 3/20 0.47
▸ HSP90AA1 P07900 1/20 0.46
▸ NPSR1 Q6W5P4 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ HTT P42858 2/20 0.45
▸ KDM4E B2RXH2 4/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ CNR1 P21554 3/20 0.43
▸ USP2 O75604 1/20 0.43
▸ SCN5A Q14524 1/20 0.42
▸ SCN9A Q15858 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ HTR2C P28335 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28092674 0.78 AVPR1A (0.57) ALDH1A1GPBAR1
SCHEMBL28092573 0.78 BCHE (0.48) MEN1KMT2AGPBAR1
SCHEMBL28092456 0.78 ALDH1A1 (0.46) SMN1; SMN2LMNAL3MBTL1MEN1KMT2A
SCHEMBL28092562 0.75 AVPR1A (0.49) SMN1; SMN2LMNANPSR1MEN1KMT2A
SCHEMBL28092475 0.74 AVPR1A (0.42) SMN1; SMN2L3MBTL1NPSR1HTTKDM4E
SCHEMBL28092615 0.74 AVPR1A (0.42) HTTALDH1A1SLC6A4GPBAR1
SCHEMBL28092812 0.74 AVPR1A (0.50) SMN1; SMN2NPSR1MEN1KMT2AALDH1A1
SCHEMBL28833101 0.74 HSD11B1 (0.44) POLBKMT2AKDM4EALDH1A1HTR2C
SCHEMBL11172201 0.74 LMNA (0.50) SMN1; SMN2POLBLMNAMETAP2METAP1
SCHEMBL28092460 0.73 AVPR1A (0.45) SMN1; SMN2LMNANPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106029076-A Benzopiperazine compositions as BET bromodomain inhibitors 福马疗法公司 2016-10-12 — — CN disclosed
Send feedback